Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Effects of in utero androgen excess and metformin treatment on hepatic functions.

Abruzzese GA, Heber MF, Ferrer MJ, Ferreira SR, Silva AF, Motta AB.

Mol Cell Endocrinol. 2019 Mar 14. pii: S0303-7207(19)30082-6. doi: 10.1016/j.mce.2019.03.006. [Epub ahead of print]

PMID:
30880153
2.

Metformin improves ovarian insulin signaling alterations caused by fetal programming.

Heber MF, Ferreira SR, Abruzzese GA, Raices T, Pignataro OP, Vega M, Motta AB.

J Endocrinol. 2019 Jan 1. pii: JOE-18-0520.R1. doi: 10.1530/JOE-18-0520. [Epub ahead of print]

PMID:
30620715
3.

Developmental programming of the female neuroendocrine system by steroids.

Abruzzese GA, Crisosto N, De Grava Kempinas W, Sotomayor-Zárate R.

J Neuroendocrinol. 2018 Oct;30(10):e12632. doi: 10.1111/jne.12632. Epub 2018 Aug 7. Review.

PMID:
29968423
4.

Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism.

Abruzzese GA, Heber MF, Ferreira SR, Velez LM, Reynoso R, Pignataro OP, Motta AB.

J Endocrinol. 2016 Jul;230(1):67-79. doi: 10.1530/JOE-15-0471. Epub 2016 May 13.

PMID:
27179108
5.

Nonalcoholic fatty liver disease in children and adolescents - Relationship with Polycystic Ovary Syndrome.

Abruzzese GA, Motta AB.

Curr Pharm Des. 2015;21(35):5144-50. Review.

PMID:
26412465
6.

The biology of the peroxisome proliferator-activated receptor system in the female reproductive tract.

Vélez LM, Abruzzese GA, Motta AB.

Curr Pharm Des. 2013;19(25):4641-6. Review.

PMID:
23565653

Supplemental Content

Loading ...
Support Center